MINNEAPOLIS, Feb 21, 2018 Invenshure portfolio company, OneOme, a healthcare technology company whose genetic test helps predict how a person will respond to hundreds of medications, announced it was named to Fast Company's World's 50 Most Innovative Companies list, as well as the Top 10 Most Innovative Companies in Biotech for 2018 in the publication's annual issue. OneOme numbered second in the Top 10 in biotech category and 22nd of 50 in the overall list.
Flywheel Exchange LLC, the collaborative science platform company, has entered into an agreement with Brain Vision, LLC to develop and sell data management for the neurophysiological research community. This solution will be the world’s first web-based automatic data capture from an electroencephalography (EEG) recording software to a central, cloud-scale database.
Flywheel, the collaborative science software company, announces the implementation of the Flywheel Center Edition at Columbia University. The system was designed for use by Columbia’s neuroscience community and their collaborators around the world, and will provide the foundation for a new paradigm in imaging research that brings together different expertise and disciplines.
The Concierge Medicine Forum held this week in Atlanta will feature an expert on pharmacogenomics from OneOme, a leading precision medicine company. Ryan Gregg, Ph.D, medical science liaison from OneOme, will present a session on pharmacogenomics on Friday, October 27, at 11:05 a.m. at the Forsyth Conference Center in Cumming, Georgia. Pharmacogenomics is an emerging field that identifies how a patient’s unique DNA and current medications may affect their response to medications.
In Singapore, OneOme and Tucker Medical are working together to help improve preventive care and oncology treatments. OneOme is a leader in pharmacogenomic testing and Tucker Medical is a multi-specialty practice offering personalized medicine and care in medical oncology, gastroenterology, and family medicine.